Restarting Mounjaro After a Break: What Actually Happens

The myth worth correcting first: you can resume at the dose you stopped

This is the assumption most people bring to a restart conversation, and it's understandable. If you were tolerating 7.5mg before the break, it feels logical to continue from there. The problem is that your body's tolerance to tirzepatide's GI effects is not stored like a setting, it resets over time. GI symptoms such as nausea, vomiting, constipation and reflux are most pronounced when the dose is new to the body; the slower you titrated originally, the better you felt. A break of several weeks essentially puts you back in that unfamiliar territory.

The NHS medicines page for tirzepatide is clear that the dose schedule should be followed as directed by your prescriber, and the underlying SmPC on the eMC advises that if doses have been missed for an extended period, re-titration should be considered. This isn't overcaution, it's the practical lesson from how GLP-1 and GIP receptor agonists behave in the body after a gap.

The short version: the dose you were on is not necessarily the dose you restart on. Your prescriber works this out with you.

What length of break actually changes about restarting Mounjaro

A brief pause (say, under two weeks) is a different situation from a month-long gap or a six-week absence. If you missed one or two injections because your pen was lost in transit or you were in hospital, the clinical picture is relatively straightforward; your prescriber may advise continuing at the same dose with added monitoring. The longer the break, the more likely a step back in dose becomes necessary.

For breaks around the one-month mark, most clinical guidance points toward restarting at 2.5mg and titrating again, though some patients with strong previous tolerance may be suitable for a slightly higher re-entry point. For longer absences, restarting Mounjaro after a month follows a very similar path to a first course. And if you've been off it for six weeks or more, the approach is essentially a fresh titration from the beginning, there is detailed guidance on restarting Mounjaro after six weeks that covers the specific considerations for that window.

What changes with a longer break is not just the dose, it's also the likelihood of some weight regain. Tirzepatide's appetite-reducing effect diminishes as the medicine clears, so a longer gap tends to mean hunger and portion sizes return toward pre-treatment levels. Factoring that into your expectations before you restart is sensible.

Storing and re-establishing your routine after the gap

One practical thing people overlook when restarting: the injection-day habit that made Mounjaro manageable. Many people anchor their weekly injection to a fixed moment, perhaps Mounjaro goes back in the fridge door between Sunday-night meal prep and the kettle. After a break, that cue disappears. Re-establishing a specific day and a specific storage spot before your pens arrive makes adherence significantly easier in the re-titration weeks, when missing an extra dose can further complicate the plan.

Storage itself is unchanged: Mounjaro pens require refrigeration at 2–8°C. The exact window for short-term room-temperature storage is detailed in the Patient Information Leaflet that comes with your pen, always follow that rather than any general guidance online, as the permitted window is specific to the formulation.

For a concise breakdown of what to expect when stepping back down through the doses, the two-week break and three-week break pages cover the shorter-gap scenarios in detail.

Getting a restart clinically reviewed, what that looks like at nume

Restarting Mounjaro isn't something you organise by simply re-ordering. A prescriber needs to know how long you've been off it, why the break happened, whether your weight or health has changed, and what dose is appropriate to re-enter at. That's true whether you're returning after a supply issue, a planned pause, or a medical event.

At nume, every repeat order (including restarts) goes through a same-day clinical review by a GPhC-registered Independent Prescriber. A real clinician reads your answers; your case isn't processed by software. If you're unsure what to expect from the Mounjaro treatment course more broadly, or want to understand what tirzepatide does at a clinical level, the tirzepatide overview covers the mechanism and the SURMOUNT trial evidence in full.

If cost is part of the reason you paused, it's worth reading the context around Mounjaro pricing in the UK before restarting, the market shifted significantly after Eli Lilly's 2025 list-price revision, and understanding what a legitimate price includes helps you avoid the unregulated sellers who advertise to people looking to resume treatment. The MHRA has warned repeatedly about counterfeit pens circulating online; this risk is particularly acute for people restarting outside a regulated pharmacy. Suspect sellers can be reported via the MHRA Yellow Card scheme.

When you're ready to talk through your specific situation and get a clinical restart plan, speak to our prescribers through a free consultation.